These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33155524)

  • 21. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
    Jain N; Shankar U; Majee P; Kumar A
    Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
    Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
    Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
    J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach.
    Srivastava S; Kamthania M; Singh S; Saxena AK; Sharma N
    Infect Drug Resist; 2018; 11():2377-2391. PubMed ID: 30538505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.
    Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S
    J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing of cytotoxic T lymphocyte-based multi-epitope vaccine against SARS-CoV2: a reverse vaccinology approach.
    Vivekanandam R; Rajagopalan K; Jeevanandam M; Ganesan H; Jagannathan V; Selvan Christyraj JD; Kalimuthu K; Selvan Christyraj JRS; Mohan M
    J Biomol Struct Dyn; 2022; 40(24):13711-13726. PubMed ID: 34696708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
    Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
    Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
    Dong R; Chu Z; Yu F; Zha Y
    Front Immunol; 2020; 11():1784. PubMed ID: 32849643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach.
    Khan T; Khan A; Ansari JK; Najmi MH; Wei DQ; Muhammad K; Waheed Y
    Molecules; 2022 Apr; 27(7):. PubMed ID: 35408772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
    Sirohi PR; Gupta J; Somvanshi P; Prajapati VK; Grover A
    J Biomol Struct Dyn; 2022 May; 40(8):3347-3358. PubMed ID: 33246394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
    Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
    Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
    PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2.
    Jalal K; Khan K; Basharat Z; Abbas MN; Uddin R; Ali F; Khan SA; Hassan SSU
    Environ Sci Pollut Res Int; 2022 Aug; 29(40):60035-60053. PubMed ID: 35414157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
    Sanami S; Alizadeh M; Nosrati M; Dehkordi KA; Azadegan-Dehkordi F; Tahmasebian S; Nosrati H; Arjmand MH; Ghasemi-Dehnoo M; Rafiei A; Bagheri N
    Comput Biol Med; 2021 Jun; 133():104390. PubMed ID: 33895459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants.
    Ezzemani W; Kettani A; Sappati S; Kondaka K; El Ossmani H; Tsukiyama-Kohara K; Altawalah H; Saile R; Kohara M; Benjelloun S; Ezzikouri S
    J Biomol Struct Dyn; 2023 Jul; 41(11):4917-4938. PubMed ID: 35549819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.